SURABHI A KHANNA

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology SAN DIEGO, CA NPI 1124220157

General Payments — all program years on this page

$11,179.81

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,489.08 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $2,120.001
Food and Beverage $369.0821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $7,955.683
2023 $735.0525
2024 $2,489.0822

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087038358 Novartis Pharmaceuticals Corporation $22.47 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104063662 ABBVIE INC. $31.72 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105569203 AstraZeneca Pharmaceuticals LP $21.21 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115808549 Amgen Inc. $14.06 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115808560 Amgen Inc. $11.25 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115808572 Amgen Inc. $11.69 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115808580 Amgen Inc. $10.85 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115808589 Amgen Inc. $11.45 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115808599 Amgen Inc. $15.99 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115808607 Amgen Inc. $16.41 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115808616 Amgen Inc. $7.73 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116669776 GlaxoSmithKline, LLC. $16.31 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117597554 Amgen Inc. $10.75 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117597556 Amgen Inc. $32.46 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117881972 Boehringer Ingelheim Pharmaceuticals, Inc. $11.85 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117881974 Boehringer Ingelheim Pharmaceuticals, Inc. $2,120.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131445345 PFIZER INC. $24.29 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143258151 UCB, Inc. $20.83 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143258155 UCB, Inc. $27.65 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143258160 UCB, Inc. $22.27 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150684624 Aurinia Pharma U.S., Inc. $13.44 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154869222 Kiniksa Pharmaceuticals International, plc $14.40 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.